Effects of 21-aminosteroid u74389f on skin-flap survival after secondary ischemia

Myoung Soo Shin, Michael F. Angel, Michael J. Im, Paul Manson

Research output: Contribution to journalArticle

Abstract

The effect of 21-aminosteroid, a lazaroid (U74389F), on tissue injury after secondary ischemia was evaluated in 3X5 cm island skin flaps in male Sprague-Dawley rats (n = 30). Primary ischemia was produced by arteriovenous occlusion for 1 hour. Eighteen hours later, secondary ischemia was inflicted by 4-hour venous occlusion. The treatment group received intravenous lazaroid (3 mg/kg) 30 minutes before the start of secondary ischemia. The control group received the same volume of citrate buffer vehicle using the same route and schedule. Skin-flap survival was an all-or-none phenomenon and assessed at 7 days after secondary ischemia.

Original languageEnglish (US)
Pages (from-to)661-666
Number of pages6
JournalPlastic and Reconstructive Surgery
Volume94
Issue number5
StatePublished - 1994

Fingerprint

Ischemia
Skin
Surgical Flaps
Citric Acid
Sprague Dawley Rats
Appointments and Schedules
Buffers
U 74389F
Control Groups
Wounds and Injuries

ASJC Scopus subject areas

  • Surgery

Cite this

Effects of 21-aminosteroid u74389f on skin-flap survival after secondary ischemia. / Shin, Myoung Soo; Angel, Michael F.; Im, Michael J.; Manson, Paul.

In: Plastic and Reconstructive Surgery, Vol. 94, No. 5, 1994, p. 661-666.

Research output: Contribution to journalArticle

Shin, Myoung Soo ; Angel, Michael F. ; Im, Michael J. ; Manson, Paul. / Effects of 21-aminosteroid u74389f on skin-flap survival after secondary ischemia. In: Plastic and Reconstructive Surgery. 1994 ; Vol. 94, No. 5. pp. 661-666.
@article{5cd54271e48f4a66bfa834a66fd241eb,
title = "Effects of 21-aminosteroid u74389f on skin-flap survival after secondary ischemia",
abstract = "The effect of 21-aminosteroid, a lazaroid (U74389F), on tissue injury after secondary ischemia was evaluated in 3X5 cm island skin flaps in male Sprague-Dawley rats (n = 30). Primary ischemia was produced by arteriovenous occlusion for 1 hour. Eighteen hours later, secondary ischemia was inflicted by 4-hour venous occlusion. The treatment group received intravenous lazaroid (3 mg/kg) 30 minutes before the start of secondary ischemia. The control group received the same volume of citrate buffer vehicle using the same route and schedule. Skin-flap survival was an all-or-none phenomenon and assessed at 7 days after secondary ischemia.",
author = "Shin, {Myoung Soo} and Angel, {Michael F.} and Im, {Michael J.} and Paul Manson",
year = "1994",
language = "English (US)",
volume = "94",
pages = "661--666",
journal = "Plastic and Reconstructive Surgery",
issn = "0032-1052",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Effects of 21-aminosteroid u74389f on skin-flap survival after secondary ischemia

AU - Shin, Myoung Soo

AU - Angel, Michael F.

AU - Im, Michael J.

AU - Manson, Paul

PY - 1994

Y1 - 1994

N2 - The effect of 21-aminosteroid, a lazaroid (U74389F), on tissue injury after secondary ischemia was evaluated in 3X5 cm island skin flaps in male Sprague-Dawley rats (n = 30). Primary ischemia was produced by arteriovenous occlusion for 1 hour. Eighteen hours later, secondary ischemia was inflicted by 4-hour venous occlusion. The treatment group received intravenous lazaroid (3 mg/kg) 30 minutes before the start of secondary ischemia. The control group received the same volume of citrate buffer vehicle using the same route and schedule. Skin-flap survival was an all-or-none phenomenon and assessed at 7 days after secondary ischemia.

AB - The effect of 21-aminosteroid, a lazaroid (U74389F), on tissue injury after secondary ischemia was evaluated in 3X5 cm island skin flaps in male Sprague-Dawley rats (n = 30). Primary ischemia was produced by arteriovenous occlusion for 1 hour. Eighteen hours later, secondary ischemia was inflicted by 4-hour venous occlusion. The treatment group received intravenous lazaroid (3 mg/kg) 30 minutes before the start of secondary ischemia. The control group received the same volume of citrate buffer vehicle using the same route and schedule. Skin-flap survival was an all-or-none phenomenon and assessed at 7 days after secondary ischemia.

UR - http://www.scopus.com/inward/record.url?scp=0028030033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028030033&partnerID=8YFLogxK

M3 - Article

C2 - 7938289

AN - SCOPUS:0028030033

VL - 94

SP - 661

EP - 666

JO - Plastic and Reconstructive Surgery

JF - Plastic and Reconstructive Surgery

SN - 0032-1052

IS - 5

ER -